Ofloxacin and ciprofloxacin resistance (MIC, >4 , ug/ml) 
Ofloxacin and ciprofloxacin resistance (MIC, >4 ,ug/ml) was encountered in 45 of 50 clinical isolates of methicillin-resistant Staphylococcus aureus. None of 20 methicillin-susceptible strains was resistant to the quinolones (P < 10-6). Quinolone-susceptible and -resistant isolates did not differ with respect to culture source or Fresh plates were seeded with inocula of 1,000 CFU by using a multipoint replicator (Cathra) and incubated for 24 h at 35°C. Incubation at 30°C was used in studies of methicillin susceptibility. The presence or absence of growth was determined for all inoculation points by a technician who used a single-blind technique. Bacteriophage typing was performed by the National Reference Laboratory.
Fifty isolates of S. aureus were found to be resistant to methicillin (MIC, >8 ,ug/ml) ( Table 1) . Of these, 45 (90%) were resistant to both ofloxacin and ciprofloxacin at concentrations of >4 p.g/ml. Twenty isolates of methicillin-susceptible S. aureus were susceptible to the quinolones (MIC, c0.5 ,ug/ml). The difference in quinolone susceptibility between the two groups of staphylococci was highly significant (P < 10-6). All (MIC, .1.0 ,ug/ml). Three strains of methicillin-resistant S. aureus were resistant to rifampin (MIC, >2 ,ug/ml).
The methicillin-resistant/methicillin-susceptible and quinolone-resistant/quinolone-susceptible S. aureus ratios during each of the three study months were similar. Epidemiologic investigations did not reveal a common source for infection. In no instance was a quinolone-resistant organism isolated from a patient following quinolone therapy. No bacteriophage type was identified among 20% of methicillinresistant and 55% of methicillin-susceptible strains. The remaining organisms were classified into 27 phage patterns (methicillin-resistant, 18; methicillin-susceptible, 9).
Many in vitro and clinical studies have suggested that the quinolone antibiotics are useful for the therapy of staphylococcal infection, including those caused by methicillin-resistant strains (1, (3) (4) (5) (7) (8) (9) (10) (11) . Isolates of methicillin-resistant, quinolone-resistant S. aureus have been described previously (6) . Such strains have appeared during the administration of quinolones (8) or were selected in vitro through serial exposure of staphylococci to increasing concentrations of ciprofloxacin (6) . In one hospital, the prevalence of quinolone resistance increased from 15 to 48% among S. aureus isolates during a 6-month period (R. D. Isaacs, P. J. Kunke, R. L. Cohen, and J. W. Smith, Letter, Lancet ii:843, 1988).
Our data raise concern as to the future usefulness of quinolones for S. aureus infection. The fact that a majority of clinical isolates of S. aureus in our hospital are resistant to both methicillin and quinolone antibiotics is of particular concern. Failure to identify a single bacteriophage type or nosocomial source suggests that we are not dealing with an isolated mutant or epidemiological aberration.
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